Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Feng-jia Chen, Li-juan Du, Zhimin Zeng, Xin-yan Huang, Chang-yi Xu, Wei-ping Tan, Can-mao Xie, Yu-xia Liang & Yu-biao Guo. (2022) PTPRH Alleviates Airway Obstruction and Th2 Inflammation in Asthma as a Protective Factor. Journal of Asthma and Allergy 15, pages 133-144.
Read now
Read now
Miao Li, Xiao Zhong & Wen-Ting Xu. (2022) Substance P promotes the progression of bronchial asthma through activating the PI3K/AKT/NF-κB pathway mediated cellular inflammation and pyroptotic cell death in bronchial epithelial cells. Cell Cycle 21:20, pages 2179-2191.
Read now
Read now
Articles from other publishers (4)
Vietdung Nguyen, Qing Zhang, Fei Pan, Qi Jin, Meng Sun, Jakkree Tangthianchaichana, Shouying Du & Yang Lu. (2023) Zi-Su-Zi decoction improves airway hyperresponsiveness in cough-variant asthma rat model through PI3K/AKT1/mTOR, JAK2/STAT3 and HIF-1α/NF-κB signaling pathways. Journal of Ethnopharmacology 314, pages 116637.
Crossref
Crossref
Hong‐Bo Liu, Juan Bai & Wen‐Xiao Wang. (2022)
CST1
promotes the proliferation and migration of
PDGF‐BB
‐treated airway smooth muscle cells via the
PI3K
/
AKT
signaling pathway
. The Kaohsiung Journal of Medical Sciences 39:2, pages 145-153.
Crossref
Crossref
Shenghao Cheng, Qingping Tang, Shaobing Xie, Sihui Wen, Hua Zhang, Zhihai Xie & Weihong Jiang. (2022) The Role of Noncoding RNA in Airway Allergic Diseases through Regulation of T Cell Subsets. Mediators of Inflammation 2022, pages 1-15.
Crossref
Crossref
Jinghui Xie, Yuedi Hu, Dengdi Sun, Changan Liu, Zegeng Li & Jie Zhu. (2022) Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases. Frontiers in Pharmacology 13.
Crossref
Crossref